News archive

Read the latest news from the nanomedicine world.
Watch the replay! ETPN & NanoVation Tx. Webinar on Next Generation LNP Technologies

Watch the replay! ETPN & NanoVation Tx. Webinar on Next Generation LNP Technologies

Oct 7, 2024

The ETPN recently hosted a groundbreaking webinar in collaboration with NanoVation Therapeutics™, bringing together nearly 600 participants to explore the future of LNP technologies for nucleic acid delivery. Discover the insights from leading experts like Pieter Cullis and Dominik Witzigmann, and access the full replay to dive into cutting-edge discussions shaping the future of nanomedicine.

ETPN Endorses Joint Statement for an Ambitious FP10 to Boost European Nanomedicine Innovation

ETPN Endorses Joint Statement for an Ambitious FP10 to Boost European Nanomedicine Innovation

Jul 4, 2024

The European Technology Platform on Nanomedicine (ETPN) proudly endorses the Joint Statement for an Ambitious FP10, published by EARTO and Business Europe. Supported by 110 European organizations, this statement calls for a significant increase in the RD&I budget and emphasizes the importance of pan-European collaborative research. The ETPN highlights the critical role of continued investment in nanomedicine to support innovative diagnostics, treatments, and nano-enabled vaccines. Discover more about our commitment to fostering European nanotechnology in healthcare.

Newly elected ETPN Executive Board for 2023-2025: Working in Continuity and Shaping the Future of Nanomedicine!

Newly elected ETPN Executive Board for 2023-2025: Working in Continuity and Shaping the Future of Nanomedicine!

Jul 19, 2023

ETPN welcomes the new Executive Board for 2023-2025, elected during the General Assembly, chaired for a second madate by Prof. Raymond Schiffelers. This Board, representing both academic and industrial expertise, pledges to advance nanomedicine under Horizon Europe, including HealthTech4EU Alliance, EIC, ERA4Health and the PPP IHI. Committed to continuity, innovation, and embracing future opportunities, we aim to accelerate the translation of nanomedicine solutions to benefit patients.

Participate in the ASTM Interlaboratory Studies on Liposomal Lipid Quantitation (summer 2023)

Participate in the ASTM Interlaboratory Studies on Liposomal Lipid Quantitation (summer 2023)

May 24, 2023

The European Technology Platform on Nanomedicine (ETPN) invites its members to partake in a scientific initiative by the FDA/ASTM International Committee E56 on Nanotechnology. The committee is conducting Interlaboratory Studies to assess the precision and bias of liposomal lipid quantitation methods. This initiative offers participating labs the chance to contribute to nanomedicine’s evolution, particularly in relation to standardization and metrological needs. The ETPN also highlights the upcoming launch of the MetrINo project, an innovative European endeavor set to contribute significantly to the Nanomed Europe 2023 conference and the broader nanomedicine landscape.

The ETPN joins the new Nanospresso-NL project for the production of nucleic acid nanomedicine at the bedside!

The ETPN joins the new Nanospresso-NL project for the production of nucleic acid nanomedicine at the bedside!

Mar 21, 2022

The project proposal NANOSPRESSO-NL will be funded by the Dutch Research Council with a 9M€ budget for the next five years. NANOSPRESSO-NL will develop a disruptive technology to make lipid nanoparticles for the delivery of RNA and DNA at the bedside, initially for orphan diseases. The ETPN will be participating in this great innovative Nanomedicine project, notably to optimize its communication and dissemination activities.

Categories:

From ETPN (36)
From the community (41)

Share your content!

If you have any news, events or job offers in the field of nanomedicine, share them with the community!

Sharing form